| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da402353017db607bf3dda98050ec120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fe6e5106f72019acb81e44825b0e44e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6df116e8af21b5301a414a958b2e8d0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate |
2006-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2436ba0e455388e27ab4323bdeca531d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fb35bdebeb7df4a509bde2ae8210ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_018bd45ccd53ebc595ff37a725d58075 |
| publicationDate |
2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007099182-A1 |
| titleOfInvention |
Comparative ligand mapping from MHC class I positive cells |
| abstract |
The present invention relates generally to a methodology for the isolation, purification and identification of peptide ligands presented by MHC positive cells. In particular, the methodology of the present invention relates to the isolation, purification and identification of these peptide ligands from soluble class I and class 11 MHC molecules which may be from uninfected, infected, or tumorigenic cells. The methodology of the present invention broadly allows for these peptide ligands and their cognate source proteins thereof to be identified and used as markers for infected versus uninfected cells and/or tumorigenic versus nontumorigenic cells, with said identification being useful for marking or targeting a cell for therapeutic treatment or priming the immune response against infected cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013143235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012009202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016199140-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377901-B2 |
| priorityDate |
2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |